Review Article

CARIES 5 Deepak R Dalai,1 Bhaskar DJ, 2 Cha ndan Agali,3 V ipul Gupta,4 Nisha Singh, Post Graduate Student, 1Professor & Head, 2 Reader, 3 Seni or Lecturer,4Post Graduate Student 5 1-4 Department of Public Health Dentistry, Teert hanker Mahavee r Dental College & Research Center, Moradabad. 5 Post Graduate student, Department of Pedodontics & Pr eventive Dentistry, Buddha Institute of Dental Sciences &Hospital, Patna

Dental caries is one of the common microbiologic and multifactorial diseases; it depends on factors such as host, agent nd rd and numerous environmental factors. Generally caries develop in between the age of 2 and 3 years in children during tooth eruption when colonization of S.mutans get started in oral cavity. This period is named as “Window of Infectivity”. Different preventive techniques have been developed against dental caries, out of which caries vaccine is one. can either be active (mucousal, systemic, activogingivo salivary) or passive (bovine milk, mouth washes, transgenic plants etc). Vaccine targets are various proteinous substances present on bacterial surface, enzymes and glucan binding proteins and therefore the protection is gained by salivary stimulation which can inhabit sucrose dependent and sucrose independent accumulation on tooth surface. Furthermore achievement of immunity is by concentration of immune response on suspected functional areas of targeted components by use of synthetic peptides and recombinant DNA technology acting as immunomodulators or vaccine deliverers. Use in humans depends on success of clinical trials in animals.

Keywords: Anti Caries DNA Vaccine, Dental caries vaccine, Mutans streptococci, Mucosal immunization.

Introduction In oral cavity colonization is by binding of agent‟s pre- existing receptors within biofilms. Initial attachment to Greater studies have been made in understanding the tooth occur by bacterial protein with dental pellicle 11 dental caries etiology. In the last century Clarke isolated streptococcus mutans1. In 2002 complete genomic sequence of S.mutans was reported.2 Indigenous microorganisms present in oral cavity are responsible for dental caries and periodontal disease3, Mutans streptococci including S.Sobrinus and S.mutans are considered to be the main cause and etiological agent of dental caries4,5. Dental caries is considered to be the major public health problem resulting by interaction b/w host, its intake diet and micro flora present on tooth surface influenced by time factor6. Many studies have been conducted in order to develop an effective vaccine for prevention of dental caries7. “A Caries is a programmed approach to pre immunized and protect caries prone people mainly children by using proteins present on oral flora bacterial surfaces mainly (antigens ) themselves for inducing human body to produce antibodies against these antigens Figure 1. Mutans streptococcal (MS) colonization of naturally”34 . humans in the first three years of life. The percentage of children colonized with mutans streptococci is indicated on History the ordinate. Percentages reflect children under modest maternal challenge (approximately 50% colonized) or Modern era regarding vaccine theory began in late 1969 children exposed to high maternal levels (approximately with intravenous immunization experiments on animals like 8 90% colonized). If high maternal MS levels (dose) are irus monkeys by William Bowen Natural history study of combined with significant exposure to dietary sucrose, oral streptococcal acquisition in infants revealed that there initial dental colonization with MS occurs at a younger age. is colonization of mutans streptococci in children b/w the age of 2nd and 3rd year of life under named circumstances of Because dental caries fulfil the criteria of infectious diet and other challenges during teeth eruption referred as diseases so its prevention is needed12 “WINDOW OF INFECTIVITY”.9So window of vaccine th th 2--Host defense system opportunity exist b/w 12 and 18 months. DNA probe technology suggests that during first year of life in caries Majority of immunoglobulin concentration in saliva is of prone patient low level of S.mutans is found in oral cavity10. IgA. IgA provide specific immune defense13.However, saliva also contain other immunoglobulin from gingival Discussion 14 sulcular fluid . These immunoglobulin acts as a specific NATURAL IMMUNE SYSTEM: agglutinin interacting with bacterial surface receptors. There is direct production of saliva by Gut Associated 1--Streptococcal pathogenesis Lymphoid tissue (GALT), In lymphoid tissue, T and B cells

TMU J Dent. Vol. 2; Issue 2. Apr – June 2015 | 48

are synthesized, the interaction of cells with saliva play part in modulation of IgA, IgG, IgH by induction of Cd4 and 15 Cd8 “the immune response and immunological memory are the basics of vaccination and revaccination”. 16, 17

3--Antigenic components of S.mutans as Activators of Immune Response:

Various antigenic components against which immu ne responses are produced are Adhesins, Glucosyltranferases, and Glucan binding proteins.18

a) Adhesins form two principle human pathogens of S.mutans (variously identified are antigen I/II, Pac or Pi).The which are directed to AgI/II molecule block adherence of S.mutans of saliva coated hydroxyappitite19,20

b) GTF An enzyme cleaving the bond b/w glucose and

fructose in sucrose and then the activated glucose is added Tonsillar route ability of tonsillar application to to glucan polymer which produces more targeted immune induce immune response. response.

c) GBP These proteins are present on surface of mutans Minor salivary gland- lips, cheeks, soft palate act as potential routes Streptococcal and act as a receptor cell for glucan mediated aggregation. GbpB has been shown to induce protective 21 Rectal immunization with non-oral bacteria such as immune response among its three types .6 Helico bacter pylori

d) Dextranases An enzyme produced by S.mutans when b) Systemic Route Of Immunization:- used as antigen prevent colonization of organisms in early dental plaque.22 By subcutaneous administration of S.mutans antibodies which find their way to oral cavity. Further achievements of immunity are by concentration of immune response on suspected functional elements of these c) Activo-Gingivo Salivary Route:

components by either using synthetic peptide or Gingival crevicular Fluid is also used as a vaccine route recombinant DNA translating complete functional associated with increased levels of IgA and IgG.26 domains.18, 19

Another approach along with case of other microorganisms is BASF in which flora is programmed against caries and they prevent binding of S.mutans to enamel.21 Phage therapy is also used for controlling oral bacterial load.23

ROUTES OF IMMUNIZATION

1) Active immunization: a) Mucosal route. b) Systemic route (subcutaneous). c) Active-gingivo salivary route.

a) Common Mucosal Immune route: 2) Passive Immunization There is an administered chimeric proteins by research which enhance mucosal immune responses to single External supplementation of antibodies can be through virulence determinants alone24.This route is most common bovine milk, mouth washes, dentifrices, egg yolk and is used for induction of salivary IgA. 25 Other route antibodies, transgenic plants. (The first plant derived vaccine from Genetically Modified Plant) 7, 25, 27 methods with mucosal immunity are: - Hence in active immunization there is induction of salivary Oral route through oral feeding of vaccine antibodies production and memory formation but in order Intranasal for GTF activation, used for sites in to establish efficacy and safety requires commitment in closer anatomical relation to oral cavity performing human trails. However in passive immunization due to preformed exogenous antibodies there is advantage of evading risks6

49 | TMU J Dent. Vol. 2; Issue 2. Apr – June 2015

Delivery Systems and Adjuvants (Immunomodulators): - References

Alone antigen was poorly immunogenic so there are 1. Smith DJ. Caries Vaccine for the twenty-first modifications of antigen preparations with adjuvant or century. J Dent Edu 2003;67(10):1130-1139. using other delivery systems to improve immunogenicity28. 2. Ajdic D, McShan WM, McLaughlin RE, Savic G, Sources and different vectors used to deliver vaccine are: Chang J, Carson MB et al. Genomic sequence of Streptococcus mutans UA159, a cariogenic dental Synthetic peptide; derived from GTF enzyme and pathogen. Proc Natl Acad Sci USA 2002; deliver vaccine to saliva. They induce their response by 99(22):14434-9. IgG and T-cell proliferation in humans. 3. Abiko Y. Passive immunization against dental Coupling of protein with cholera toxin B caries and periodontal disease: Development of Subunit protein is Ag I/II, it is powerful recombinant and human monoclonal antibodies immunoadjuvant and suppress S.mutans colonization. Crit Rev Oral Biol Med 2000;11(2):140-158. 4. Smith DJ, Godiska R. Passive immunization Coupling of protein with salmonella attenued approaches for dental caries prevention. Confrence mutant vectors such as Salmonella, which contain Proceedings. Egg Symposium 2004:1-6. plasmids expressing recombinant peptides, can target 5. Roa NS, Gomez SI, Rodriquez A. Cytokines the vaccine to appropriate inductive lymphoid tissue for produced by CD4+ T cells against a synthetic mucosal responses.32 GTF-I (1301-1322) peptide of streptococcus mutans in naturally sensitized humans. Acta Microcapsules, macrocapsules (Polylactide-co Odontol Latinoam 2008;21(2):153-158. glycolide) because of ability of slow degradation and 6. Russell MW, Childers NK, Michalek SM, Smith controllable releasing rate they are used as local DJ, Taubmen MA. A caries vaccine? The state of delivery system e.g. PLGA(poly lactide -co-glycolide) science of immunization against dental caries.

Liposomes phospholipids membrane vesicles, and Caries Res 2004;38(3):230-5. facilitates M-cell uptake and delivery of antigen to 7. Shivakumar KM, Vidya SK, Chandu GN. Dental active antibody producing areas of lymphoid tissue.7, 23, caries vaccine. Indian J Dent Res 2009;20(1):99- 29,30,31,32 106. Risks of Use of Caries Vaccine 8. Krithika AC, Kandaswamy D, Krishna VG. Caries Vaccine-1. Today‟s myth. J Indian Assoc Public Introduction of crude form of S.mutans vaccine induce Health Dent 2004;4:21-25. antibodies production that not only react against those 9. Caufield PW, Cutter GR, Dasanayake AP. Initial specific antigens but also against heart tissues33usually in acquisition of mutans streptococci by infants: rheumatic fever patient they are heart cross reactive. So evidence for a discrete window of infectivity. J vaccine should be pure enough with removal of specifically Dent Res 1993;72(1):37-45. epitope on AgI/II due to which it causes heart reactivity.32, 10. Milgrom P, Riedy CA, Weinstein P, Tanner AC, 33 Manibusan L, Bruss J. Dental caries and its relationship to bacterial , hypoplasia, diet Public Health Aspects th Developing countries without system, and oral hygiene in 6 to 36 month old children. poor access to dental health education are in great need of Community Dent Oral Epidemiol 2000;28(4):295- vaccine. An effective safe and readily available vaccine 306. may not only help to fight against pain but save billions of 11. Russell MW, Lehner T. Characterization of money spend on restorative treatment.7, 1, 34 antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol Conclusion 1978;23(1):7-15. 12. Lehne T Immunology of dental caries. Active and Passive Immunization strategies to work against rd pathogenesis of S.mutans in oral cavity hold promise. Immunology of Oral Diseases 3 edition However to make it practical in humans it depends on Blackwell Scientific Publications; 1992. clinical findings and their results outcome in animals. Main 13. Fan MW, Bian Z, Peng ZX, Zhong Y, Chen Z, goal concerned with their use in humans is that it should be Peng B et al. A DNA vaccine encoding a cell- safe and as caries is gradual developing process so the surface protein antigen of streptococcus mutans vaccine administered should also be long-lasting and protects gnotobiotic rats from caries. J Dent effective and should have increasing impact in high risk Res2002;81(11):784-787. population. Thus, a successful vaccination of dental caries 14. Newman MG, Nisengard RJ. Oral microbiology could be a valuable immunomodulator as compared to other and immunology. W.B.Sander‟s Company; 1988. caries preventive measures.7,1,34 15. Russell RR, Johnson NW. The prospects for vaccination against dental caries. Br Dent J 1987;162(1):29-34.

TMU J Dent. Vol. 2; Issue 2. Apr – June 2015 | 50

16. Park K. Textbook of Preventive and Social antibodies to a cell surface protein antigen- Medicine .17th edition. Bhanotidas Publication: glucosyltranferase fusion protein protects rats 2004. against dental caries. Infect Immun 17. Warren L, Ernest J. Medical microbiology and 2002;70(5):2721-2724. immunology 6th edition. Lange medical publishing 33. Hajishengallis G, Michalek SM. Current status of division 2000. a mucosal vaccine against dental caries. Oral 18. Koga T, Oho T, Shimazaki Y, Nakano Y. Microbiol Immunol 1999;14(1):1-20. Immunization against dental caries vaccine. 34. Hiremath SS. Textbook of preventive and Vaccine 2002;20(16):2027-44. community dentistry. India:ELSEVIER:2009.338- 19. Smith DJ. Dental caries vaccine; prospects and 42. concerns. Crit Rev Oral Biol Med 2002;13(4):335- 349. Corresponding Author

20. Guo JH, Jia R, Fan MW, Bian Z, Chen Z, Peng B. Dr.D.J.Bhaskar Construction and immunologic characterization of Professor & Head, fusion of anti-caries DNA vaccine against PAc & Department of Public Health Dentistry, glucosyltransferase 1 of Streptococcus mutans. J Teerthanker Mahaveer Dental College & Research Centre, Dent Res 2004;83(3):266-270. Bagarpur, Moradabad, Uttar Pradesh, INDIA 21. Russell MW. Potential for vaccine in the Email- [email protected] prevention of caries lesions. Operative Dent 2001;26(s6):51-60. 22. Chewing gum with added bite. British Dent J 2006;201:255. 23. Bachrach G, Leizerovici-Zigmond M, Zlotkin A, Naor R, Steinberg D. Bacteriophage isolation from human saliva. Lett Appl Microbiol 2003;36(1):50- 53. 24. Zhang P, Jespersgaard C, Lamberty-Mallory L, Katz J, Huang Y, Hajishengallis G et al. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of streptococcus mutans and protection against infection. Infect Immun 2002;20(12):6779-87. 25. Russel MW. Hajishengalis G, Childers NK, Michalek SM. Secretory immunity in defense against cariogenic mutans streptococci. Caries Res 1999;33(1):4-15. 26. Tandon S. Textbook of pedodonrics.1st edition. Paras publishing:2001. 27. Genes „n‟ greens: the future of oral medicine? Br Dent J 2002;192(12):674. 28. Panel on Caries Vaccine . National Institutes of Dental and Craniofacial Research 2003. 29. Oon, Smith TL, Taubman ML, et al. Expression and delivery of GTF peptides in Salmonella enterica J. Dent Research,81 30. Smith DJ, King WF, Barnes LA, Peacock Z, Taubman MA. Immunogenicity and protective immunity induced by synthetic peptides assossciated with putative immunodominant regions of Streotococcus mutans glucan binding protein B. Infect Immun 2003;71(3):1179-84. 31. Saito M, Otake S, Ohmura M, Hirasawa M, Takada K, Mega J et al. Protective Immunity to s.mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant. J Infect Dis 2001;183(5):823-826. 32. Mitoma M, Oho T, Michibata N, Okano K, Nakano Y, Fukuyama M et al. Passive immunization with bovine milk containing

51 | TMU J Dent. Vol. 2; Issue 2. Apr – June 2015